Hochschulschrift
Developing new chimeric antigen receptor (CAR)-engineered natural killer cells targeting ovarian cancer stem cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Hannover, Medizinische Hochschule Hannover, Dissertation, 2017
- Schlagwort
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Hannover
- (wer)
-
Bibliothek der Medizinischen Hochschule Hannover
- (wann)
-
2017
- Urheber
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:gbv:354-20170616193
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Wang, Shuo
- Hillemanns, Peter
- Klinik für Frauenheilkunde und Geburtshilfe
- Bibliothek der Medizinischen Hochschule Hannover
Entstanden
- 2017
Ähnliche Objekte (12)
High cytotoxic efficiency of lentivirally and alpharetrovirally engineered CD19-specific chimeric antigen receptor natural killer cells against acute lymphoblastic leukemia
Tumor-associated Natural Killer cells in ovarian cancer ascites: Molecular and functional characterization
Chimeric antigen receptor (CAR)-engineered NK-92 cells : an off-the-shelf cellular therapeutic for universal tumor targeting
Chimeric toxins for specific targeting of cancer cells
A Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capability to Activate Natural Killer Cells
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
Interaction of endothelial cells and natural killer cells
Interaction of Endothelial Cells and Natural Killer Cells
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Investigation of TRAIL resistance in ovarian cancer cell lines and translational application in primary ovarian cancer cells
High cytotoxic efficiency of lentivirally and alpharetrovirally engineered CD19-specific chimeric antigen receptor natural killer cells against acute lymphoblastic leukemia
Tumor-associated Natural Killer cells in ovarian cancer ascites: Molecular and functional characterization
Chimeric antigen receptor (CAR)-engineered NK-92 cells : an off-the-shelf cellular therapeutic for universal tumor targeting
Chimeric toxins for specific targeting of cancer cells
A Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capability to Activate Natural Killer Cells
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
Interaction of endothelial cells and natural killer cells
Interaction of Endothelial Cells and Natural Killer Cells
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Investigation of TRAIL resistance in ovarian cancer cell lines and translational application in primary ovarian cancer cells
High cytotoxic efficiency of lentivirally and alpharetrovirally engineered CD19-specific chimeric antigen receptor natural killer cells against acute lymphoblastic leukemia
Tumor-associated Natural Killer cells in ovarian cancer ascites: Molecular and functional characterization
Chimeric antigen receptor (CAR)-engineered NK-92 cells : an off-the-shelf cellular therapeutic for universal tumor targeting
Chimeric toxins for specific targeting of cancer cells
A Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capability to Activate Natural Killer Cells
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
Interaction of endothelial cells and natural killer cells
Interaction of Endothelial Cells and Natural Killer Cells
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia